CV Lattes
ORCID
Abstract
B-cell neoplasms represent a significant portion of hematologic malignancies and are associated with therapeutic challenges due to the toxicity of conventional treatments and recurrence. CAR-T cell therapy is characterized by the use of chimeric antigen receptors (CAR) with the ability to redirect the cytotoxic activity of modified T cells in a target-specific manner, as demonstrated by t…